Compound 1664
Identifiers
- Common name: NPD158
- Canonical SMILES:
Oc1cccc(C(=O)C=Cc2ccccc2O)c1O
- IUPAC name:
(2E)-1-(2,3-dihydroxyphenyl)-3-(2-hydroxyphenyl)prop-2-en-1-one
- InChi:
InChI=1S/C15H12O4/c16-12-6-2-1-4-10(12)8-9-13(17)11-5-3-7-14(18)15(11)19/h1-9,16,18-19H
- InChiKey:
HVYFGDLINYPWGI-UHFFFAOYSA-N
External links
![]() 78074572 |
![]() CHEMBL2180473 |
External search
|
|
|
|
|
Bibliography (1)
Pharmacological data
| Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|
| 1 | 0 | 0 | 0 |
Targets
| PPI family | Best activity | Diseases | MMoA |
|---|---|---|---|
| LEDGF / IN | 5.79 | HIV infectious disease | Inhibition |
Physicochemical filters
| Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
|---|---|---|---|---|
| Compliance | ||||
| MW | 256.07 g/mol | |||
| HBA | 4 | |||
| HBD | 3 | |||
| HBA + HBD | 7 | |||
| AlogP | 3.63 | |||
| TPSA | 77.76 | |||
| RB | 3 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
| Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 |
| Ta | Structure | Name | Drugbank ID |
|---|---|---|---|
| 0.7945 | Isoliquiritigenin | DB03285 | |
| 0.7073 | Dihydroxymethoxychalcone | DB14122 | |
| 0.6517 | (2E)-1-[2-hydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | DB07500 | |
| 0.6444 | Xanthohumol | DB15359 | |
| 0.5500 | 2-Hydroxybenzalpyruvate | DB08636 | |
| 0.5300 | Flaviolin | DB02521 | |
| 0.5273 | Sofalcone | DB05197 | |
| 0.5221 | 3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE | DB07230 | |
| 0.5135 | trans-2-hydroxycinnamic acid | DB01650 | |
| 0.5065 | 2,4-Dihydroxy-Trans Cinnamic Acid | DB01704 | |
| 0.5000 | Tapinarof | DB06083 | |
| 0.5000 | 4-(2-METHOXYPHENYL)-2-OXOBUT-3-ENOIC ACID | DB08637 | |
| 0.5000 | Dienestrol | DB00890 | |
| 0.4898 | BMS-181156 | DB02466 | |
| 0.4779 | Elafibranor | DB05187 |




